ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
Dow Jones
42.992,21
-0,77%
Euro vs US Dollar
1,0424
-0,04%
Bitcoin
93.579,22
-1,64%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Genelux Corporation (GNLX)

  7. Genelux Corporation (GNLX) News

GNLX

Genelux (GNLX)

Genelux Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GNLX
DatumZeitQuelleÜberschriftSymbolFirma
21/12/202402h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
21/12/202402h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
21/12/202402h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
21/12/202402h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
21/12/202402h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
21/12/202402h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
18/12/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
18/12/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
18/12/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
18/12/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
13/12/202413h01GlobeNewswire Inc.Genelux Corporation to Participate in a Fireside Chat with H.C. WainwrightNASDAQ:GNLXGenelux Corporation
14/11/202422h05GlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
22/10/202422h12Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GNLXGenelux Corporation
22/10/202422h01GlobeNewswire Inc.Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung CancerNASDAQ:GNLXGenelux Corporation
21/10/202423h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
09/10/202422h15GlobeNewswire Inc.Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:GNLXGenelux Corporation
03/10/202423h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
26/09/202422h44Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GNLXGenelux Corporation
14/09/202400h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
13/09/202402h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
12/09/202400h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
11/09/202422h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
07/09/202401h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
06/09/202423h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
03/09/202422h01GlobeNewswire Inc.Genelux Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:GNLXGenelux Corporation
31/08/202401h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
28/08/202401h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
22/08/202423h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
14/08/202422h05GlobeNewswire Inc.Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
14/08/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
 Showing the most relevant articles for your search:NASDAQ:GNLX

Kürzlich von Ihnen besucht

TG
RHM
Rheinmetall
COIN
XRPUSD
Ripple
DBI
SDXP
SDAX
AMEX
SPY
SPDR S&P 500
TG
CBK
Commerzbank
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
TG
TUI1
Tui
TG
D7G
Nel ASA
PM
XAUUSD
Gold vs US Dollar
TG
LHA
Deutsche Lufthansa
TG
432
Arbor Metals
FX
EURJPY
Euro vs Yen
TG
NOV
Novo Nordisk
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten